Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
 |
UNAIDS - November 26, 2007
"I have been reflecting on exactly what 'violence' in the violence against women means. The more I thought about the subject, the more I realized that violence now has many shapes and colours, it has transcended the violence of physical, sexual and psychological assault, touched down on political and economic harm and now moved into the space of complicity by silence," Ms Mataka said.
Highlighting the recent epidemiological data released by UNAIDS and WHO, Ms Mataka underlined that approximately 60% of HIV adults living with HIV in sub-Saharan Africa are women. "This information, I am aware, is not new - women in our region have for many years been what has been coined 'the face of the epidemic' - but what this new data has done is brought home the realization that nothing, nothing has changed for women. When it comes to women, why are we so slow to act?" she said.
"With statistics such as these, we are facing a critical emergency, we are rapidly moving towards an Africa without women. Allowing this to happen is violence against women. You may not conduct a physical assault, but being silent is being complicit and non-action is now a violent act," she added.
The 16 Days of Activism Against Gender Violence is an international campaign that was started by the Center for Women's Global Leadership (CWGL) in 1991. The 16 Days runs from November 25, International Day Against Violence Against Women to December 10, International Human Rights Day to symbolically link violence against women and human rights and to emphasize that such violence is a violation of human rights.
This 16-day period also highlights other significant dates including December 1- World AIDS Day.
071126
UN071108
Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .